E-poster
HCC
Yi-Chung Hsieh O-017 Hepatitis B core-related antigen is a predictive factor for non-B, non-C hepatocellular carcinoma
Qingbiao Lin P-107 The Validation of GALAD Model in Diagnosis of Hepatocellular Carcinoma
Ming-Tsung Lin P-108 The Expression, Prognosis and Functional Role Of CD105 In Hepatocellular carcinoma
Yuan-Hung Kuo P-109 The outcome of patients with hepatitis B virus related hepatocellular carcinoma using sorafenib in Taiwan
Chung-Feng Huang P-110 Lower protein expression levels of membrane MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection
Hung-Wei Wang P-111 Modified Fibrosis-4 index stratifies the risk of hepatocellular carcinoma in Asian patients with chronic hepatitis B treated with entecavir
Yi-Shen Wei P-112 Palliative paracentesis in home hospice care for patients with hepatocellular carcinoma and liver cirrhosis
Hui-Fen Chen P-113 Transcatheter arterial chemoembolization combined with Sorafenib versus Sorafenib alone for BCLC stage C hepatocellular carcinoma: a retrospective study
Shu Yein Ho P-114 Noninvasive prognostic models for patients with hepatocellular carcinoma undergoing radiofrequency ablation
Hsiao Sheng Lu P-115 The effect of primary prophylaxis therapy for large esophageal varices in patients with hepatocellular carcinoma
Hsueh-Hao Chang P-116 Diagnostic performance of Gadoxetic acid-enhanced MRI for hepatocellular carcinoma: a retrospective study of 65 patients
Wei Teng P-117 Albumin-Bilirubin grade predicts prognosis of HCC patients with repeated TACE
Yilin Chen P-118 Optimal Subclassification Of BCLC Stage B Hepatocellular Carcinoma
Cheng-Pin Wu P-119 Tumor detection and identification by using Real-Time Virtual Sonography before local regional ablation
Chen-Ta Chi P-120 Radiological Features and Outcomes of Mixed Hepatocellular and Cholangiocarcinoma in Patients undergoing Surgical Resection
Kebin Chang P-121 Role of Sorafenib Combined Transcatheter Arterial Chemoembolization (TACE) in Patients with Advanced Hepatocellular Carcinoma
Xi Hsuan Lin P-122 Ten Years Experiences of Transarterial Chemoembolization in Patients with Treatment-Naïve Hepatocellular Carcinoma
Po-Chun Chen P-123 Treatment to Solitary Huge Hepatocellular Carcinoma (HCC) – Resection is better than Transarterial Chemoembolization (TACE)
Chung-Yu Chang P-124 The role of albumin-bilirubin grade in determining the long-term outcomes of patients with BCLC stage 0 HCC
Yi-Chung Hsieh P-125 Switching multiple-electrode radiofrequency ablation for a single hepatocellular carcinoma up to 7 cm
Tony Kuo P-126 Comprehensive evaluation of the receptor tyrosine kinase family in human hepatocellular carcinogenesis
Ming-Lun Yeh P-127 Total Bilirubin Level Predict Survival in Hepatitis B related Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Treatment
Ming-Lun Yeh P-128 Viral Eradication Prolong Over Survival in Hepatitis C related Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Treatment
Chien-Wei Peng P-129 An investigation for the risk factors and prognosis in HCC patients receiving transarterial chemoembolization with postembolization fever
Wei Chih Sun P-130 Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis
Meng-Yu Chen P-131 Liver resection for hepatocellular carcinoma with a zero resection margin
Tsung-Hui Hu P-132 Signatures of resistance associated genes in sorafenib/ regorafenib enriched hepatocellular carcinoma cells
Chin Wei Yen P-133 Did AFP-L3 save ultrasonography in community screen?
Batbold Batsaikhan P-134 Characteristics of Clinical Features of Hepatocellular Carcinoma in Southern Taiwan